Sade Biotech is excited to introduce our new head nurse – Jenny Arieli
Sade Biotech is excited to introduce our new head nurse, Jenny Arieli, as head of the ASAYA Patient Support Program. We are happy to share Jenny’s personal (always…) words A personal note from our new head Nurse: Hello! I’m Jenny. A mom to a starting ballerina. A 3rd generation nurse in my family. Graduated from […]
Sade Biotech pioneers the accessibility of medical cannabis treatment for Alzheimer’s and Dementia patients
In January 2022, the Ministry of Health in Israel approved the use of medical cannabis to treat Dementia and Alzheimer’s in the adult population. Sade Biotech, the company behind ASAYA™ big-data platform, in cooperation with the National Pain Center, assist Alzheimer’s and dementia patients in the process of obtaining approval and then continuous monitoring of […]
Sadé Biotech And Its ASAYA™ Software Can now be Marketed in Europe
Excited to share with you that our ASAYA system was successfully registered with the Belgian Federal Agency for Medicines and Health Products and it is now CE marked. In addition, Sade Biotech and its ASAYA platform achieved the certification of several ISO Standards, including: ISO27001:2013, ISO27799:2016, and ISO 13485:2016. Our choice to walk the unbeaten […]
Sade Biotech Enters Exciting Collaboration with Leading Israeli Rehabilitation Center
At Sade, we’re always looking for new ways to collect, analyze, and harness collective wisdom on everything medical cannabis (MC), in order to provide the scores of people around the world living with chronic pain and debilitating conditions with the relief they so desperately deserve. Upon doing our due diligence, we came to understand that […]
Sade Biotech Welcomes New Team Member Itzik Hamo
Sade Biotech is on a mission to harness the power of collective wisdom to transform medical cannabis care. To achieve this goal, the leading scientific research and development company recently welcomed Itzik Hamo to the team as VP Customer Engagement. The former CEO of FEMI Premium, Israel’s largest telemedicine company, Itzik joined Sade to lead […]
New ASAYA PSP Head Naama Saban-Ohana to Integrate Cannabis Experience with Patient-Centric Support
Sade Group welcomes our newest recruit, Naama Saban-Ohana, with open arms, A certified nurse and former Head of Training & Education and VP Customer Services for Tikkun Olam, Naama will be heading up the ASAYA Patient Support Program (ASAYA PSP). Her unparalleled experience ideal positions her for overseeing the treatment of thousands of medical cannabis […]
The Upside of Covid-19: More Individualized Medical Cannabis Care
The Covid-19 pandemic has driven widespread adoption of digital data and technology across all sectors and industries, including medical cannabis, so as to provide higher levels of personalization, without compromising on standardization. Here, data is translated into knowledge and insights, to provide patients with the best, most-effective, and safest treatments. That being said, medical cannabis […]
Big Data Analysis to Improve Medical Cannabis Patient Care
When used in the healthcare context, the term “Real-World Data” (RWD) usually refers to patient-level data gathered outside the conventional clinical trial setting. Such data may be generated in the course of normal clinical practice or administrative claims processing or may be reported directly by patients4.Clinical evidence that is derived from the analysis of RWD […]
